Clinical trials: Autosomal Dominant RYR1-Related Myopathy
Autosomal Dominant RYR1-Related Myopathy
A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy
This study is testing a medicine called surlorian in adults who have a genetic muscle condition known as autosomal dominant RYR1-related myopathy (RYR1-RM).
- Trial name
- NCT07560020
- Testing
- Surlorian
- Where
- 9 sites in France, Germany and 3 more
- Volunteers
- 28 people
- Sponsor
- RyCarma Therapeutics, Inc.